Therapeutic effectiveness of drugs as determined by DESI reports. II.
D045930:Anabolic Agents / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy; D000779:Anesthetics, Local / Q000627:therapeutic use; D000871:Anthelmintics / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D013956:Antithyroid Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D004341:Drug Evaluation; D004358:Drug Therapy; D057487:Enzyme Therapy; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy; D011372:Progestins / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D013566:Sympathomimetics / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy
D045930:Anabolic Agents; D000700:Analgesics; D000728:Androgens; D000779:Anesthetics, Local; D000871:Anthelmintics; D000925:Anticoagulants; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000932:Antiemetics; D000978:Antiparkinson Agents; D013956:Antithyroid Agents; D001993:Bronchodilator Agents; D004967:Estrogens; D007004:Hypoglycemic Agents; D011372:Progestins; D013566:Sympathomimetics; D013963:Thyroid Hormones